CHPA opens 2026 Awards for OTC marketing innovations
The awards spotlight strategic innovation and execution across key categories, including digital marketing, multicultural and inclusive campaigns, shopper marketing, and product launches.
CHPA
CHPA elects new members and names 2027 Chair-Elect at Annual Summit
鈥淐HPA is privileged to be guided by outstanding industry leaders who volunteer their time and expertise to serve on our board of directors,鈥澛爏aid CHPA President and CEO Scott Melville.
CHPA honors Fuad Sawaya With 2026 Combe Lifetime Achievement Award
Sawaya has been deeply involved with CHPA for more than two decades, serving as a trusted advisor to member companies and contributing to broader industry dialogue around consumer healthcare.
O-T-C medicines play central role in how Americans manage health, new study reveals
National survey of 21,000 sdults captures seven-day snapshot of medication use; OTC and prescription medicines used in tandem to address distinct health needs.
Industry groups praise introduction of Dietary Supplement Regulatory Uniformity Act
Legislation reaffirms the FDA is the sole authority to regulate dietary supplements, reinforcing a single, national standard for ingredient safety and oversight.
2026 Health Care Outlook: Scott Melville, CHPA
By Scott Melville, president and CEO of the Consumer Healthcare Products Association
CHPA backs new dietary guidelines
CHPA appreciates the ongoing recognition that dietary supplements support individuals in meeting nutrient needs when diet alone falls short.
CHPA applauds bill to accelerate OTC innovation
CHPA said the bill would boost OTC market innovation by clarifying and standardizing the review process for new and updated self-care products.
CHPA鈥檚 Health In Hand Foundation holds 10th Anniversary Gala
Over 350 industry leaders from 100 companies gathered at The Bellevue Hotel for this milestone event and a major fundraiser for the Foundation鈥檚 consumer education initiatives.
Proposed acetaminophen warning conflicts with FDA鈥檚 standard that OTC labels be 鈥淐lear and Truthful鈥�
Discouraging acetaminophen use when taken as directed by a health professional could push pregnant patients toward NSAIDs or no treatment, both of which can adversely affect pregnancy outcomes.
CHPA disputes autism claims and defends acetaminophen safety
Decades of use, FDA safety reviews, and leading medical groups confirm the safety of acetaminophen when used as directed.
CHPA releases statement on APAP use during pregnancy
鈥淐urrent research has not established a聽causal link between acetaminophen use and adverse neurodevelopmental outcomes.鈥�
CHPA鈥檚 Health In Hand Foundation announces 2025 U.S. Self-Care Marketing Awards finalists
This year鈥檚 competition had the highest participation rate since its inception in 2019, with a 32% increase in submissions over 2024.
CHPA鈥檚 Health In Hand Foundation launches national back-to-school health campaigns
Backed by CHPA member companies Kenvue and Colgate-Palmolive, and developed in collaboration with The Skin Cancer Foundation and the American Dental Association (ADA), the programs will reach more than 1.2 million students nationwide during the back-to-school season.
FDA Center heads to take the stage together at CHPA Regulatory Conference
Each year, CHPA鈥檚 RSQ Conference unites industry, regulators, and academia to focus on the evolving self-care sector.
Illinois expands consumer access to PSE and strengthens support for the system that prevents diversion
"The passage of HB 3087 represents a significant victory for both consumer access and public safety,鈥澛爏aid Carlos Gutierrez, vice president of State & Local Government Affairs at CHPA.聽